medigraphic.com
ISSN 1561-302X (Print)

2021, Number 3

<< Back Next >>

Rev cubana med 2021; 60 (3)

Behavior of comorbidities in mortality of patients with chronic heart failure

Roselló AY, Alzate BC, Rojas GA, Chao PC

Language: Spanish
References: 38
Page: 1-17
PDF size: 407.22 Kb.


ABSTRACT

Introduction: Heart failure is a worldwide problem and will increase in the coming years as a result of population aging. It is associated with multiple comorbidities that may be involved in its development, contribute to the progression of the disease, or worsen the prognosis.
Objective: To assess the influence of comorbidities on the mortality of patients with chronic heart failure.
Methods: A retrospective cohort study was carried out in 242 patients with a diagnosis of chronic heart failure and a mean follow-up of 5 years in the heart failure protocol consultation at Hermanos Ameijeiras Surgical Clinical Hospital. The magnitude of the association between the presence of comorbidities and mortality was determined through the use of logistic regression.
Results: The mean age was higher in deceased patients 72.12 ± 12.088 years (p = 0.003). The isolated presence of comorbidities did not show an association with mortality, but it did when more than two comorbidities coexisted. (OR: 2.91. CI: .991-8.61). A linear association was found between the number of comorbidities and mortality (p = 0.044).
Conclusion: The studied comorbidities did not show an independent association with mortality, but the sum of them did increase the risk of death in patients with heart failure.


REFERENCES

  1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139(10):56-528. Disponible en: https://doi.org/10.1161/CIR.0000000000000659

  2. Feinstein AR. The pre-therapeutic classification of Co- Morbidity in chronic diseases. J Chronic Dis. 1970;23:455-68. Disponible en: https://doi.org/10.1016/0021-9681(70)90054-8

  3. Holm AL, Berland AK, Severinsson E. Managing the needs of older patients with multimorbidity- A systematic review of the challenges faced by the healthcare services. Open Journal of Nursing. 2016[acceso: 26/04/2019];6:881-901. Disponible en: Disponible en: http://www.scirp.org/journal/ojn

  4. Andrade R, Silvera G. Manejo de las comorbilidades en la insuficiencia cardíaca. Rev Urug Cardiol. 2018;33:57-70. http://dx.doi.org/10.29277/cardio.33.1.1

  5. Tisminetzky M, Gurwitz J, Fan D, Reynolds K, Smith D, Magid D, et al. Multimorbidity burden and adverse outcomes in community- based cohort of adults with heart failure. J Am Geriatr Soc. 2018;66:2305-13. Disponible en: https://doi.org/10.1111/jgs.15590

  6. Christiansen MN, Køber L, Weeke P, Vasan RS, Jeppesen JL, Smith JG, et al. Age-specific trends in incidence, mortality, and comorbidities of heart failure in Denmark, 1995 to 2012. Circulation. 2017;135(13):1214-23. Disponible en: https://doi.org/10.1161/CIRCULATIONAHA.116.025941

  7. Upadhya B, Rocco M, Lewis CE, Oparil S, Lovato LC, Cushman WC, et al. Effect of intensive blood pressure treatment on heart failure events in the systolic blood pressure reduction intervention trial. Circ Heart Fail. 2017;10(4):e003613. Disponible en: https://doi.org/10.1161/CIRCHEARTFAILURE.116.003613

  8. Gerber Y, Weston SA, Enriquez M, Berardi C, Chamberlain AM, Manemann SM, et al. Mortality associated with heart failure after myocardial infarction: a contemporary community perspective. Circ Heart Fail. 2016;9(1):e002460. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002460

  9. Agrinier N, Thilly N, Briançon S, Juillière Y, Mertes PM, Villemot JP, et al. Prognostic factors associated with 15-year mortality in patients with hospitalized systolic HF: Results of the observational community-based EPICAL cohort study. Int J Cardiol. 2017;228:940-7. Disponible en: https://doi.org/10.1016/j.ijcard.2016.11.260

  10. Stewart S, Riegel B, Boyd C, Ahamed Y, Thompson DR, Burrell LM, et al. Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): A multidisciplinary position statement. Int J Cardiol. 2016;212:1-10. Disponible en: https://doi.org/10.1016/j.ijcard.2016.03.001

  11. Campbell RT, McMurray JJ. Comorbidities and differential diagnosis in heart failure with preserved ejection fraction. Heart Fail Clin. 2014;10(3):481-501. Disponible en: https://doi.org/10.1016/j.hfc.2014.04.009

  12. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2017;70(6):776-803. Disponible en: https://doi.org/10.1016/j.jacc.2017.04.025

  13. Cuba. Ministerio de Salud Pública. Anuario Estadístico de Salud 2018. 2018[acceso: 18/07/2019]. Disponible en: Disponible en: http://bvscuba.sld.cu/anuario-estadistico-de-cuba/

  14. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147-239. Disponible en: https://doi.org/10.1161/CIR.0b013e31829e8776

  15. Braunschweig F, Linde C, Benson C, Stahlberg M, Dahlstrom U, Lund LH. New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy. Eur J Heart Fail. 2017;19:366-76. Disponible en: https://doi.org/10.1002/ejhf.563

  16. Ponikowski P, Voors A, Anker A, Bueno H, Cleland J, Coats A, et al. Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Rev Esp Cardiol. 2016;69(12):1167.e1-e85. Disponible en: https://doi.org/10.1093/eurheartj/ehw128

  17. Anguita M, Crespo MG, de Teresa E, Jiménez M, Alonso L, Muñiz J, et al. Prevalencia de la insuficiencia cardíaca en la población general española mayor de 45 años. Estudio PRICE. Rev Esp Cardiol. 2015[acceso: 14/02/2019];61:1041-94. Disponible en: Disponible en: https://www.revespcardiol.org/es-prevalencia-insuficiencia-cardiaca-poblacion-general-articulo-13126044

  18. González JR, Alegría E, Bertoméu V, Conthe P, de Santiago A, Zsolt I. Insuficiencia cardíaca en consultas ambulatorias: comorbilidades y actuaciones diagnóstico-terapéuticas por diferentes especialistas. Estudio EPISERVE. Rev Esp Cardiol. 2014[acceso: 14/12/2018];61:611-95. Disponible en: Disponible en: https://www.revespcardiol.org/es-insuficiencia-cardiaca-consultas-ambulatorias-comorbilidades-articulo-13123067

  19. Conde ME, Arkuch F, Formiga L, Manzano O, Aramburu Á, González MF, et al. Diferencias en función del sexo en el perfil clínico y pronóstico de pacientes con insuficiencia cardiaca. Rev Clin Esp. 2015[acceso: 22/02/2018];215(7):363-70. Disponible en: Disponible en: https://www.revclinesp.es/es-diferencias-funcion-del-sexo-el-articulo-S0014256515000892

  20. Fernández EM, Figueroa DA. Tabaquismo y su relación con las enfermedades cardiovasculares. Rev haban cienc med. 2018[acceso: 02/04/2018];17(2). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2018000200008

  21. Triviño L, Avila JC, Ramírez-Vélez R. La paradoja de la obesidad y su relación con la aptitud cardiorrespiratoria en pacientes con insuficiencia cardíaca. Rev Colomb Cardiol. 2015[acceso: 08/07/2020];22(5). Disponible en: Disponible en: https://creativecommons.org/licenses/by-nc-nd/4.0/

  22. Sze S, Pellicori P, Kazmi S, Rigby A, Cleland J, Wong K, Clark AL. Prevalence and prognostic significance of malnutrition using 3 scoring systems among outpatients with heart failure. Jacc Heart Failure. 2018;6:476-86. Disponible en: https://doi.org/10.1016/j.jchf.2018.02.018

  23. Franco J, Formiga F, Chivite D, Manzano L, Carrera M, Arévalo JC, et al. RICA investigadors. New onset heart failure-Clinical characteristics and short-term mortality. A RICA (Spanish registry of acute heart failure) study. Eur J Intern Med. 2015;26:357-62. Disponible en: https://doi.org/10.1016/j.ejim.2015.04.008

  24. Josa C, Sola A, Giménez I, Rubio J, Garcés V, Pérez JI. Valor pronóstico de la ratio urea/creatinina en la insuficiencia cardiaca descompensada y su relación con el daño renal agudo. Rev Clin Esp. 2018[acceso: 12/05/2019];218(5):232-40. Disponible en: Disponible en: https://medes.com/publication/135924

  25. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011). 2017;7(1):1-59. Disponible en: https://doi.org/10.1016/j.kisu.2017.04.001

  26. Buchaca E, Camargo H, Tamargo T, Rodríguez L. Valor pronóstico de los trastornos de la glucemia en la insuficiencia cardíaca congestiva. Rev Cubana Med. 2018[acceso: 18/04/2019];57(2). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232018000200003&lng

  27. American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(1):13-27. Disponible en: https://doi.org/10.2337/dc18-S002

  28. Catapano A, Graham I, De Baker G, Wiklund O, Chapman J, Drexel H, et al. Guía ESC/EAS 2016 sobre el tratamiento de las dislipidemias. Rev Esp Cardiol. 2017;70(2):115.e1-e64. Disponible en: https://doi.org/10.1016/j.rec.2017.01.002

  29. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436-48. Disponible en: https://doi.org/10.1056/NEJMoa0908355

  30. Ponikowski P, van Veldhuisen DJ, Comin J, Ertl G, Komajda M, Mareev V, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015;36:657-6m. Disponible en: https://doi.org/10.1016/j.rec.2017.01.002

  31. Streng K, Nauta J, Hillege H, Anker S, Cleland J, Dikstein K, et al. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. Int J Cardiol. 2018;271:132-39. Disponible en: https://doi.org/10.1016/j.ijcard.2018.04.001

  32. Chivite D, Formiga F, Corbella X, Conde A, Aramburu Ó, Carrera M, et al. Basal functional status predicts one-year mortality after a heart failure hospitalization in elderly patients-The RICA prospective study. Int J Cardiol. 2018;254:182-8. Disponible en: https://doi/10.1016/j.ijcard.2017.10.104

  33. Pan American Health Organization. Health conditions in the Americas. Scientific Publication. 524. Washington DC, PAHO/WHO, 2016[acceso: 01/06/2020]. Disponible en: Disponible en: https://iris.paho.org/handle/10665.2/28379

  34. Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT, et al. Potential US population impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation. 2018[acceso: 01/06/2020];137(2):109-18. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/29133599/

  35. Pérez MD, León JL, Dueñas A, Navarro DA, de la Noval R, del Pozo H, et al. Guía Cubana de diagnóstico, evaluación y tratamiento de la hipertensión arterial. Rev Cubana Med. 2017[acceso: 14/05/2019];56. Disponible en: Disponible en: http://files.sld.cu/hta/files/2018/02/guia-Cubana-de-Diagnostic0-Evaluacion-y-Tratamiendo-de-la-HTA-2017.pdf

  36. López JE, Villar AL. Dislipidemia en personas mayores de 60 años. Rev Cubana Med Gen Integr. 2005[acceso: 24/07/2018];21(3). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252005000300004

  37. Franco J, Formiga F, Chivite D, Manzano L, Carrera M, Arévalo JC, et al. RICA investigators. New onset heart failure-Clinical characteristics and short-term mortality. A RICA (Spanish registry of acute heart failure) study. Eur J Intern Med. 2015;26:357-62. Disponible en: https://doi.org/10.1016/j.ejim.2015.04.008

  38. Mogensen UM, Ersbøll M, Andersen M, Andersson C, Hassager C, Torp-Pedersen C, et al. Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups. Eur J Heart Fail. 2014;13:1216-23. Disponible en: https://doi.org/10.1093/eurjhf/hfr116




2020     |     www.medigraphic.com